FDA
approval
· 2011-01-28
FDA Approved: ULORIC — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
Summary
The FDA approved a supplemental application for ULORIC (febuxostat) submitted by Takeda Pharmaceuticals America, Inc. This notice indicates an approval of a sup…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ULORIC (FEBUXOSTAT)